| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/13/2008 | WO2007109376A3 Anti-tumor cell antigen antibody therapeutics |
| 03/13/2008 | WO2007108013A3 Novel bioconjugates as therapeutic agent and synthesis thereof |
| 03/13/2008 | WO2007042281A3 Processing of chitosan and chitosan derivatives |
| 03/13/2008 | US20080064854 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/13/2008 | US20080064765 antiandrogenetic agent finasteride and blood-sugar modulating agent saxagliptin for treating alopecia |
| 03/13/2008 | US20080064763 solid amorphous dispersions of low-solubility drugs and hydroxypropyl methyl cellulose alkanyl phthalate; enhance physical stability, absorption of drug in vivo, drug's bioavailability; fluvastatin HMG-CoA reductase inhibitor |
| 03/13/2008 | US20080064762 Composition Comprising a Pharmacologically Active Agent Coupled to a Target Cell Specific Component, and a Saponin |
| 03/13/2008 | US20080064761 salt tolerance skin-care body gel is irritation-free; high melting wax containing esters of pentaerythritol, dipentaerythritol and/or tripentaerythritol; cosmetics |
| 03/13/2008 | US20080064760 Spontaneously Dispersible Pharmaceutical Composition |
| 03/13/2008 | US20080064759 Process for preparing fenofibrate compositions |
| 03/13/2008 | US20080064713 Dry Syrup Containing Loratadine |
| 03/13/2008 | US20080064711 Composition for treating oral cavity and Mucousal infections |
| 03/13/2008 | US20080064675 And crystal growth inhibitors for drugs, pesticides, herbicides, proteins, amino acids, vitamins, or antibiotics, preferably modafinil, drospirenone, eplerenone, raloxifene or anetholtrithione; vanillin, ethylvanillin, trans-anethole, or coumarin; nontoxic |
| 03/13/2008 | US20080064672 Compositions containing topical active agents and pentyleneglycol |
| 03/13/2008 | US20080064649 Anticarcinogenic and antiproliferative agents in combination with radiation therapy, chemotherapy, ablative surgery, or partially ablative surgery for bone and breast cancer treatments |
| 03/13/2008 | US20080064640 Particularly drugs and cosmetic agents; ethoxylated meadowform oil having between 10 and 19 ethoxy units, and the delivered agent, especially analgesics, antiinflammatory agents or antiwrinkle agents; improved penetration and bioavailability |
| 03/13/2008 | US20080064628 Injectable synthetic blood clotting compositions containing peptide bound to insoluble carrier; selectively binding activated platelets to fibrinogen; treating wounds in patients with thrombocytopenia |
| 03/13/2008 | US20080064602 Herbicide, pesticide, parasiticide or miticide milled together with calcium carbonate, dispersants, surfactants and disintegrants in a water-soluble carrier chosen from acrylic ester-acrylamide copolymer, polyacrylic acid or crosslinked polysodium acrylate; gel or pastes; improved ease of application |
| 03/13/2008 | US20080064101 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 03/13/2008 | US20080063727 Human growth hormone, bovine, somatotropin, growth hormone releasing hormone, peptide; injection formulation dispersed in medium of buffered aqueous solution, ethanol, propyleneglycol, polyethyleneglycol, vegetable oil, mineral oil; aerosol formulation water-soluble hyaluronic acid, inorganic salt |
| 03/13/2008 | US20080063726 Micronized fenofibrate; polyvinylpyrrolidone, polyvinyl alcohol, hydroxypropylcellulose hydrophilic polymer; sodium lauryl sulfate, monooleate, monolaurate, monopalmitate surfactant; starch, colloidal silica, cross-linked polyvinyl pyrrolidone inert hydrosoluble carrier particles; hypolipemiant |
| 03/13/2008 | US20080063721 Sustained release microparticle; a biodegradable and biocompatible polymer; active agent risperidone, 9-hydroxy-risperidone; pharmaceutically acceptable acid addition salts; inhibiting serotonergic or dopaminergic overstimulation |
| 03/13/2008 | US20080063720 Delivery System |
| 03/13/2008 | US20080063716 Polymerizing alkenoate monomers, ethylene glycol diacrylate cross-linking agent; form a suspension of hydrogel particles; delivering a biologically active agent in vivo; biomedical applications, joint reconstruction, wound repair, drug delivery, cosmetic surgery |
| 03/13/2008 | US20080063714 Triazene derivatives non-covalently crosslinked are non-polymeric, carboxy functional groups, partial aromatic or heteroaromatic character; matrix stable in acidic environment of the stomach; will dissolve in non-acidic environment of intestine; matrix will protect a drug from enzymatic degradation |
| 03/13/2008 | US20080063708 Low solubility drug dispesed in concentration enhancing hydroxypropyl methyl cellulose acetate succinate (or phthalate), cellulose acetate phthalate, (or trimellitate), carboxymethyl ethyl cellulose, hydroxypropyl methyl cellulose, poloxamers, polyvinylpyrrolidone,or polyvinyl alcohol; bioavailability |
| 03/13/2008 | US20080063704 Storage stability, waterproof; microcrystalline cellulose as diluent; magnesium stearate as lubricant; hard gelatin capsule |
| 03/13/2008 | US20080063698 Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
| 03/13/2008 | US20080063696 Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant |
| 03/13/2008 | US20080063690 Nut skin products |
| 03/13/2008 | US20080063686 POLYLACTIDE ENGINEERED TO BE ABSORBED INTO BODY AT LOW SPEED FOR SIDE EFFECT REDUCTION; membrane has a varying cross-sectional thickness |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063660 inducing specific anti-drug antibodies using drug conjugated immunogen (bacterial toxoid) to reduce a drug's toxicity; drug is cocaine, nicotine, heroin, opium, morphine, marijuana, or antineoplastic; immunogen induces production of antibodies which sequester a subsequently administered drug; drug abuse |
| 03/13/2008 | US20080063639 Method for the treatment of psoriasis comprising novel anti-IGF-IR antibodies |
| 03/13/2008 | US20080063633 Fusion proteins comprising single chain FV fragment of an antibody, and transport proteins, used for treatment of skin cancer |
| 03/13/2008 | US20080063626 Minimization of drug oxidation in drug irradiated excipients formulations |
| 03/13/2008 | US20080063620 biodegradable amphiphillic copolymers comprising hydrophobic and hydrophillic segments, capable of undergoing transitions that results in an increase in viscosity in response to a change in temperature, used for drug delivery, prevention of surgical adhesions, as bioadhesives and in tissue engineering |
| 03/13/2008 | US20080063618 a mixture of zinc pyrithione in combination with water soluble zinc containing materials such as zinc oxide and anionic, cationic, nonionic, amphoteric or zwitterionic surfactants, used as antidandruff agents with improved efficacy |
| 03/13/2008 | US20080063607 Oleaginous pharmaceutical and cosmetic foam |
| 03/13/2008 | US20080063606 Pulmonary delivery of aminoglycoside |
| 03/13/2008 | US20080063598 chimeric antibodies, fragments, polypeptides and derivatives that preferentially bind tumor associated antigens (AF-20), useful in the treatment and diagnosis of cancers |
| 03/13/2008 | US20080060645 Dry Powder Inhalant Composition |
| 03/13/2008 | US20080060641 Methods and systems for operating an aerosol generator |
| 03/13/2008 | DE19905801B4 Verfahren zur Herstellung folienförmiger Darreichungsformen Process for producing film-like administration forms |
| 03/13/2008 | DE10224607B4 Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung In film form, disintegratable formulations for drug delivery and methods for their preparation |
| 03/13/2008 | DE10107659B4 Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin Mucoadhesive disintegratable pharmaceutical preparation for drug delivery in veterinary and human medicine |
| 03/13/2008 | CA2663003A1 Compositions and methods for enhancing transport through mucus |
| 03/13/2008 | CA2662607A1 Composition comprising reduced coenzyme q10 and lysolecithin |
| 03/13/2008 | CA2662439A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 03/13/2008 | CA2662434A1 Topical compositions |
| 03/13/2008 | CA2662350A1 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 03/13/2008 | CA2661830A1 Dry powder compound formulations and uses thereof |
| 03/13/2008 | CA2661280A1 Mucosal and systemic adjuvants comprising glycolipids,corresponding conjugates and pharmaceutical compositions. |
| 03/13/2008 | CA2660685A1 Aqueous formulation comprising an antitumor agent |
| 03/12/2008 | EP1897886A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 03/12/2008 | EP1897561A1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 03/12/2008 | EP1897560A1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 03/12/2008 | EP1897559A1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 03/12/2008 | EP1897558A1 Solid preparation |
| 03/12/2008 | EP1897557A1 Use of glycolipids as adjuvants |
| 03/12/2008 | EP1897556A1 Prevention and treatment of hypergastrinemia |
| 03/12/2008 | EP1897550A2 Prodrugs of Excitatory Amino Acids |
| 03/12/2008 | EP1897542A1 Aqueous formulation comprising an antitumor agent |
| 03/12/2008 | EP1897536A1 Surface cross-linked lipidic particles, methods of production and uses therefor |
| 03/12/2008 | EP1896507A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 03/12/2008 | EP1896085A1 Peptides whose uptake by cells is controllable |
| 03/12/2008 | EP1896082A2 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
| 03/12/2008 | EP1896081A1 Human granulocyte-colony stimulating factor isoforms |
| 03/12/2008 | EP1896080A2 Toxin peptides with extended blood halflife |
| 03/12/2008 | EP1896079A1 Dendrimers multivalently substituted with active groups |
| 03/12/2008 | EP1896078A1 Estrogen compositions for vaginal administration |
| 03/12/2008 | EP1896077A2 Methods and compositions for the prevention and treatement of inflammatory disease |
| 03/12/2008 | EP1896072A2 A direct drug delivery system based on thermally responsive biopolymers |
| 03/12/2008 | EP1896016A2 Method for solubilizing metronidazole |
| 03/12/2008 | EP1895982A2 Stable nanoparticle formulations |
| 03/12/2008 | EP1895960A1 Transdermal delivery of cannabinoids |
| 03/12/2008 | EP1686972B1 Sprayable composition for the administration of vitamin d derivatives |
| 03/12/2008 | EP1658047B1 Spray-dried amorphous powder with a low residual moisture and excellent storage stability |
| 03/12/2008 | EP1524967B1 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
| 03/12/2008 | EP1494654B1 Palatable chewable tablet |
| 03/12/2008 | EP1450751B1 Nanoparticle delivery vehicle |
| 03/12/2008 | EP1411986B1 Composition comprising epigallocatechin gallate |
| 03/12/2008 | EP1408999B1 Compositions addressing inflammation and/or degenerative disorders |
| 03/12/2008 | EP1307194B1 Fentanyl composition for nasal administration |
| 03/12/2008 | EP1292611B1 Glycopeptide carboxy-saccharide derivatives |
| 03/12/2008 | EP1265648B1 NOVEL collagen-BASED MATERIAL WITH IMPROVED PROPERTIES FOR USE IN HUMAN AND VETERINARY MEDICINE AND THE METHOD OF MANUFACTURING SUCH |
| 03/12/2008 | EP1037657B1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101142485A Use of antibody-surrogate antigen systems for detection of analytes |
| 03/12/2008 | CN101141975A Vegf拮抗剂制剂 Vegf antagonist preparations |
| 03/12/2008 | CN101141974A Protein introducing carrier, protein introducing agent given by using the carrier, method for introducing the protein, protein introduced cell, and method for producing the cell |
| 03/12/2008 | CN101141971A Stabilised plant extract and its therapeutic use |
| 03/12/2008 | CN101141961A Stable particular pharmaceutical composition of solifenacin or salt thereof |
| 03/12/2008 | CN101141952A New soft capsules |
| 03/12/2008 | CN101141948A Drug delivery compositions and related methods |
| 03/12/2008 | CN101139410A Polyphenylacetylene stabilization emulsion and preparation method thereof |
| 03/12/2008 | CN101139304A Conjugated dienamides and uses thereof |
| 03/12/2008 | CN101138635A Fibrin glue vasodilation agent sustained-release long-acting composition |
| 03/12/2008 | CN101138629A Recombinant human keratinocyte growth factor-2 freeze dried agent |
| 03/12/2008 | CN101138622A Prescription of mouth ulcer bilayer film and technique of preparing the same |